Morishima Y, Kawase T, Malkki M, Petersdorf E W
Aichi Cancer Center, Nagoya, Japan.
Tissue Antigens. 2007 Apr;69 Suppl 1:31-5. doi: 10.1111/j.1399-0039.2006.759_3.x.
Population-based differences in clinical outcome after unrelated donor hematopoietic cell transplantation suggest that the significance of human leukocyte antigen (HLA) mismatching may be related to locus-specific and allele-specific differences that distinguish ethnically diverse transplant donors and recipients. We studied the risks associated with HLA-A locus mismatching in two large transplant populations from the International Histocompatibility Working Group in hematopoietic cell transplantation data set to better understand permissible and nonpermissible HLA-A mismatches.
非亲缘供者造血细胞移植后临床结局的人群差异表明,人类白细胞抗原(HLA)错配的意义可能与区分不同种族移植供者和受者的基因座特异性及等位基因特异性差异有关。我们在国际组织相容性工作组造血细胞移植数据集中的两个大型移植人群中研究了与HLA - A基因座错配相关的风险,以更好地理解可允许和不可允许的HLA - A错配情况。